Renaissance Lakewood, LLC, a pharmaceutical contract development and manufacturing organization (CDMO), has opened their new headquarters at 1215 Paco Way in Lakewood, NJ. 

The facility spans 81,000 square feet and increases Renaissance Lakewood’s GMP warehouse capacity as well as serves as the primary client engagement and administrative hub for the company. The 14,000 square foot office space portion of the building is now fully occupied, and the 67,000 square foot warehouse will be online by Q3 of this year.

“Creating an environment where our clients feel welcome and supported is of paramount importance to us as a CDMO,” said Serge Maltais, president and CEO, Renaissance Lakewood, LLC. “This brand-new space allows us to not only provide a technologically advanced engagement experience, but also offers our employees who work in this facility the opportunity to enjoy upgraded amenities and collaborative workspaces.”

Renaissance Lakewood, LLC provides nasal and sterile injectable dosage forms and has developed and commercialized these products for U.S. and global markets.

The multi-million-dollar expansion and facilities upgrade of their now 370,000 square foot main campus footprint in Ocean County, NJ, began in 2020 and consists of two new buildings as well as the renovation of their former headquarters building in Lakewood, NJ. An investment in state-of-the-art technology and equipment is also part of the modernized structures.

The 1200 Paco Way building has long served as the organization’s main manufacturing facility. Lab space, packaging operations, administrative offices, and warehousing capabilities are all housed at the 177,000 square foot location, which has remained open throughout the construction.

“Expanding our footprint and making critical investments in our technology infrastructure are critically important to our success as a CDMO,” Maltais said. “We have spent nearly a decade upgrading our facilities and capabilities to meet the world-wide demand for our broad range of services. This new campus master plan is critical to preparing for the future growth of the company which includes nasal sprays, injectable products, R&D services, and secondary packaging.”